Subcellular Targeting-Based Advanced Therapy Via Chemically Designed Nanodrug
iScience Notes · 2022
DOI: 10.22580/iscinotej7.7.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift iScience Notes, 2022. Verfasst von Ankan K. Sarkar und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Although the origin of disease and drug targets are primarily at intracellular space, such targeting is not achievable in currently available drugs. We and others recently show that molecular drugs can be transformed into nanodrug for better subcellular targeting with the enhanced therapeutic performance. This can be achieved via appropriate size and surface chemistry of colloidal nanodrug to control or bypass the endocytic uptake and intracellular trafficking processes. This approach can be adapted for enhanced drug performance with lower side effects.
Zitieren
APA
Sarkar, A. K., & Jana, N. R. (2022). Subcellular Targeting-Based Advanced Therapy Via Chemically Designed Nanodrug. iScience Notes. https://doi.org/10.22580/iscinotej7.7.3
Vancouver
Sarkar AK, Jana NR. Subcellular Targeting-Based Advanced Therapy Via Chemically Designed Nanodrug. iScience Notes. 2022. doi:10.22580/iscinotej7.7.3
BibTeX
@article{Sarkar2022,
author = {Sarkar, Ankan K. and Jana, Nikhil R.},
title = {Subcellular Targeting-Based Advanced Therapy Via Chemically Designed Nanodrug},
journal = {iScience Notes},
year = {2022},
doi = {10.22580/iscinotej7.7.3}
}
EUVIMED